Journal for Immunotherapy of Cancer names paper by Christian Capitini ‘best’ of 2023

Christian Capitini, MD

The previously published manuscript, “Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regression,” was voted the Best Immune Cell Therapies and Immune Cell Engineering Paper of 2023 by the Journal for Immunotherapy of CancerChristian Capitini, MD, associate professor and chief, Division of Hematology, Oncology, and Bone Marrow Transplant, was a corresponding author on the paper.